Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate and PMR for Migraine in ED
NCT02945839Phase 4Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of topiramate in migraine, sponsored by NYU Langone Health. Planned start Dec 2016; status: withdrawn.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02945839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02945839.